Metastatic prostate cancer comes in two forms, which could guide treatment
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide …
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide …
Breast cancer: Dr Chris on 'breakthrough' Enhertu drug We use your sign-up to provide content in ways you’ve consented to …
A simple finger test could determine early signs of lung cancer, it has been reported. People are being urged to …
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This …
Scientists from The Hospital for Sick Children (SickKids) and the Montreal Children’s Hospital of the McGill University Health Centre have …
Eating fructose appears to alter cells in the digestive tract in a way that enables it to take in more …
Lung cancer is the leading cause of cancer-related death. Current treatments employ immunotherapy, often in combination with chemotherapy, but benefits …
Princess Margaret Cancer Centre researchers have made new findings which provide a broader understanding of how dormant hematopoietic stem cells …
Gateway for Cancer Research℠ awards grant to the EORTC 1634- Brain Tumour Group (BTG) academic trial in Post-Pubertal Patients with …
Living organisms are often exposed to stress stimuli generated either by external or internal factors, and they need to respond …
The newly issued comprehensive ‘Oncology Medical Home’ standards can act as a roadmap for how practices can deliver high-quality cancer …
Evidence shows that early detection and treatment of cancer can significantly improve health outcomes, however women in Mississippi, particularly in …
Rapid evolution in the field of biomedical research demands well-trained scientists. Adapting biomedical research training programs to keep up with …
The Princess Máxima Center for pediatric oncology is to embark on a close collaboration with German top centers in Heidelberg …
Researchers from the Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the LIH Department of Oncology (DONC) are working on the development of …
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than …
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than …
Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines–in some cases, …